VALIDATION OF A NOVEL MOLECULAR-ORBITAL APPROACH (COMPACT) FOR THE PROSPECTIVE SAFETY EVALUATION OF CHEMICALS, BY COMPARISON WITH RODENT CARCINOGENICITY AND SALMONELLA MUTAGENICITY DATA EVALUATED BY THE UNITED-STATES NCI NTP

被引:56
作者
LEWIS, DFV [1 ]
IOANNIDES, C [1 ]
PARKE, DV [1 ]
机构
[1] UNIV SURREY,SCH BIOL SCI,MOLEC TOXICOL GRP,GUILDFORD GU2 5XH,SURREY,ENGLAND
来源
MUTATION RESEARCH | 1993年 / 291卷 / 01期
关键词
MOLECULAR STRUCTURE; CYTOCHROMES P450; COMPUTER GRAPHICS; AMES TEST; SAFETY EVALUATION; RODENT CARCINOGENICITY;
D O I
10.1016/0165-1161(93)90018-U
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular dimensions and electronic structures of 100 chemicals of structural diversity have been determined from molecular orbital calculations and molecular mechanics. From these parameters of molecular structure, those chemicals that are likely substrates of cytochromes P4501 and P4502E have been identified by the computer-optimized molecular parametric analysis of chemical toxicity (COMPACT) programme, and their potential toxicity, mutagenicity and carcinogenicity evaluated. The degree of correlation between COMPACT prediction of toxicity and rodent two species life-span carcinogenicity data is estimated to be 92%, and between COMPACT and Salmonella mutagenicity (Ames test) data is 64%. Anomalous rodent carcinogens are rationalized on the basis of biochemical mechanisms of metabolism, genotoxicity and carcinogenicity. Correlation of the Ames test data with rodent carcinogenicity data was 64%, but correlation of COMPACT plus Ames data versus rodent carcinogenicity data provided the highest correlation of 94%.
引用
收藏
页码:61 / 77
页数:17
相关论文
共 39 条
  • [1] TOO MANY RODENT CARCINOGENS - MITOGENESIS INCREASES MUTAGENESIS
    AMES, BN
    GOLD, LS
    [J]. SCIENCE, 1990, 249 (4972) : 970 - 971
  • [2] FURTHER-STUDIES ON THE PHARMACOKINETICS OF PERHEXILINE-MALEATE IN HUMANS
    AMOAH, AGB
    GOULD, BJ
    PARKE, DV
    LOCKHART, JDF
    [J]. XENOBIOTICA, 1986, 16 (01) : 63 - 68
  • [3] ANTILLA S, 1991, INT J CANCER, V7, P681
  • [4] BENOXAPROFEN KINETICS IN RENAL IMPAIRMENT
    ARONOFF, GR
    OZAWA, T
    DESANTE, KA
    NASH, JF
    RIDOLFO, AS
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (02) : 190 - 194
  • [5] ARYTON AD, 1992, MUTAT RES, V265, P1
  • [6] CHEMICAL-STRUCTURE, SALMONELLA MUTAGENICITY AND EXTENT OF CARCINOGENICITY AS INDICATORS OF GENOTOXIC CARCINOGENESIS AMONG 222 CHEMICALS TESTED IN RODENTS BY THE UNITED-STATES NCI/NTP
    ASHBY, J
    TENNANT, RW
    [J]. MUTATION RESEARCH, 1988, 204 (01): : 17 - 115
  • [7] CARCINOGEN METABOLISM AND DNA ADDUCTS IN HUMAN LUNG TISSUES AS AFFECTED BY TOBACCO SMOKING OR METABOLIC PHENOTYPE - A CASE-CONTROL STUDY ON LUNG-CANCER PATIENTS
    BARTSCH, H
    PETRUZZELLI, S
    DEFLORA, S
    HIETANEN, E
    CAMUS, AM
    CASTEGNARO, M
    GENESTE, O
    CAMOIRANO, A
    SARACCI, R
    GIUNTINI, C
    [J]. MUTATION RESEARCH, 1991, 250 (1-2): : 103 - 114
  • [8] CLASSIFICATION OF CARCINOGENS - POLEMICS, PEDANTICS, OR PROGRESS
    CLAYSON, DB
    CLEGG, DJ
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1991, 14 (02) : 147 - 166
  • [9] OMEPRAZOLE IS AN ARYL HYDROCARBON-LIKE INDUCER OF HUMAN HEPATIC CYTOCHROME-P450
    DIAZ, D
    FABRE, I
    DAUJAT, M
    SAINTAUBERT, B
    BORIES, P
    MICHEL, H
    MAUREL, P
    [J]. GASTROENTEROLOGY, 1990, 99 (03) : 737 - 747
  • [10] THE IMPORTANCE OF PHARMACOKINETIC AND RECEPTOR STUDIES IN DRUG SAFETY EVALUATION
    EASON, CT
    BONNER, FW
    PARKE, DV
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1990, 11 (03) : 288 - 307